Skip to main content
. 2023 Apr 18;51(W1):W134–W140. doi: 10.1093/nar/gkad275

Figure 2.

Figure 2.

Score distribution of DeepNeo-tcr-v1 and DeepNeo-tcr-v2 models. In model test set (A), external validation set (B), cancer patient cohort (C), score distributions indicate that DeepNeo-tcr-v2 of both classes can better discriminate spatial interaction of pMHC that elicit immune response and represent known neoantigen behavior.